Patent · US Active

Pantoprazole multiparticulate formulations

US7553498B2 · kind B2 · utility

4Cited by
58References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 30, 2007
Grant dateJun 30, 2009
Priority date
Expiry dateMar 30, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/1652
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating gastroesophageal reflux disease (GERD), ulcers of the stomach or duodenum, or Zollinger-Ellison Syndrome in a human, by administering pantoprazole sodium multiparticulates is described. The pantoprazole multiparticulates have a spheroid core of pantoprazole or an enantiomer thereof, or a salt thereof, a surfactant, and a disintegrant; a sub coat which is comprised of hydroxypropyl methylcellulose (hypromellose) and water, an enteric coat on the subcoat, and a final seal coat over the enteric coat, which is composed of hydroxypropyl methylcellulose (hypromellose) and water.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.